Search

everythinglearnresearchcommunity

for

Search:↓

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Menopause affects hair and skin; more research needed for treatment.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Visible light can improve skin disorders and hair loss, but more research is needed to understand long-term effects.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

PCOS requires personalized treatment to improve life quality and reduce health risks.

Combining letrozole with metformin is the most effective treatment for inducing pregnancy in women with PCOS.

Most women with excessive hair growth have a hormonal cause.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.

Polycystic Ovary Syndrome (PCOS) is common in infertile women and obese women with PCOS have more severe ovulatory problems, needing more care.